Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Merit Medical Systems (MMSI) Raw Materials (2018 - 2025)

Historic Raw Materials for Merit Medical Systems (MMSI) over the last 11 years, with Q3 2025 value amounting to $113.5 million.

  • Merit Medical Systems' Raw Materials rose 25.53% to $113.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $113.5 million, marking a year-over-year increase of 25.53%. This contributed to the annual value of $110.5 million for FY2024, which is 756.62% down from last year.
  • As of Q3 2025, Merit Medical Systems' Raw Materials stood at $113.5 million, which was up 25.53% from $117.0 million recorded in Q2 2025.
  • Merit Medical Systems' 5-year Raw Materials high stood at $119.6 million for Q4 2023, and its period low was $54.6 million during Q1 2021.
  • Its 5-year average for Raw Materials is $94.7 million, with a median of $108.0 million in 2024.
  • In the last 5 years, Merit Medical Systems' Raw Materials crashed by 2881.77% in 2021 and then skyrocketed by 5222.98% in 2023.
  • Merit Medical Systems' Raw Materials (Quarter) stood at $67.4 million in 2021, then surged by 32.73% to $89.4 million in 2022, then soared by 33.72% to $119.6 million in 2023, then decreased by 7.57% to $110.5 million in 2024, then rose by 2.68% to $113.5 million in 2025.
  • Its Raw Materials stands at $113.5 million for Q3 2025, versus $117.0 million for Q2 2025 and $118.4 million for Q1 2025.